Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice

Eleonora Calcagno, Sara Guzzetti, Alessandro Canetta, Claudia Fracasso, Silvio Caccia, Luigi Cervo, Roberto W. Invernizzi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We recently found that the response of DBA/2 mice to SSRIs in the forced swim test (FST) was impaired and they also had a smaller basal and citalopram-stimulated increase in brain extracellular serotonin (5-HT) than responder strains. We employed intracerebral microdialysis, FST and selective antagonists of 5-HT1A and 5-HT2C receptors to investigate whether enhancing the increase in extracellular 5-HT reinstated the anti-immobility effect of citalopram in the FST. WAY 100635 (0.3 mg/kg s.c.) or SB 242084 (1 mg/kg s.c.), respectively a selective 5-HT1A and 5-HT2C receptor antagonist, raised the effect of citalopram (5 mg/kg) on extracellular 5-HT in the medial prefrontal cortex of DBA/2N mice (citalopram alone 5.20.3 fmol/20 l, WAY 100635+citalopram 9.92.1 fmol/20 l, SB 242084+ citalopram 7.61.0 fmol/20 l) to the level reached in responder mice given citalopram alone. The 5-HT receptor antagonists had no effect on the citalopram-induced increase in extracellular 5-HT in the dorsal hippocampus. The combination of citalopram with WAY 100635 or SB 242084 significantly reduced immobility time in DBA/2N mice that otherwise did not respond to either drug singly. Brain levels of citalopram in mice given citalopram alone or with 5-HT antagonists did not significantly differ. The results confirm that impaired 5-HT transmission accounts for the lack of effect of citalopram in the FST and suggest that enhancing the effect of SSRIs on extracellular 5-HT, through selective blockade of 5-HT1A and 5-HT2C receptors, could be a useful strategy to restore the response in treatment-resistant depression.

Original languageEnglish
Pages (from-to)793-803
Number of pages11
JournalInternational Journal of Neuropsychopharmacology
Volume12
Issue number6
DOIs
Publication statusPublished - Jul 2009

Fingerprint

Receptor, Serotonin, 5-HT2C
Citalopram
Antidepressive Agents
Serotonin
Inbred DBA Mouse
Serotonin Antagonists
Serotonin 5-HT1 Receptor Antagonists
Treatment-Resistant Depressive Disorder
Serotonin 5-HT2 Receptor Antagonists
Serotonin Receptors
Microdialysis
Brain
Prefrontal Cortex
Hippocampus

Keywords

  • 5-HT1A receptors
  • 5-HT2C receptors
  • FST
  • Intracerebral microdialysis
  • SSRIs
  • TPH-2

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Psychiatry and Mental health
  • Medicine(all)

Cite this

Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice. / Calcagno, Eleonora; Guzzetti, Sara; Canetta, Alessandro; Fracasso, Claudia; Caccia, Silvio; Cervo, Luigi; Invernizzi, Roberto W.

In: International Journal of Neuropsychopharmacology, Vol. 12, No. 6, 07.2009, p. 793-803.

Research output: Contribution to journalArticle

@article{66a953956c39495f94361a9571a8d88d,
title = "Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice",
abstract = "We recently found that the response of DBA/2 mice to SSRIs in the forced swim test (FST) was impaired and they also had a smaller basal and citalopram-stimulated increase in brain extracellular serotonin (5-HT) than responder strains. We employed intracerebral microdialysis, FST and selective antagonists of 5-HT1A and 5-HT2C receptors to investigate whether enhancing the increase in extracellular 5-HT reinstated the anti-immobility effect of citalopram in the FST. WAY 100635 (0.3 mg/kg s.c.) or SB 242084 (1 mg/kg s.c.), respectively a selective 5-HT1A and 5-HT2C receptor antagonist, raised the effect of citalopram (5 mg/kg) on extracellular 5-HT in the medial prefrontal cortex of DBA/2N mice (citalopram alone 5.20.3 fmol/20 l, WAY 100635+citalopram 9.92.1 fmol/20 l, SB 242084+ citalopram 7.61.0 fmol/20 l) to the level reached in responder mice given citalopram alone. The 5-HT receptor antagonists had no effect on the citalopram-induced increase in extracellular 5-HT in the dorsal hippocampus. The combination of citalopram with WAY 100635 or SB 242084 significantly reduced immobility time in DBA/2N mice that otherwise did not respond to either drug singly. Brain levels of citalopram in mice given citalopram alone or with 5-HT antagonists did not significantly differ. The results confirm that impaired 5-HT transmission accounts for the lack of effect of citalopram in the FST and suggest that enhancing the effect of SSRIs on extracellular 5-HT, through selective blockade of 5-HT1A and 5-HT2C receptors, could be a useful strategy to restore the response in treatment-resistant depression.",
keywords = "5-HT1A receptors, 5-HT2C receptors, FST, Intracerebral microdialysis, SSRIs, TPH-2",
author = "Eleonora Calcagno and Sara Guzzetti and Alessandro Canetta and Claudia Fracasso and Silvio Caccia and Luigi Cervo and Invernizzi, {Roberto W.}",
year = "2009",
month = "7",
doi = "10.1017/S1461145708009760",
language = "English",
volume = "12",
pages = "793--803",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "6",

}

TY - JOUR

T1 - Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice

AU - Calcagno, Eleonora

AU - Guzzetti, Sara

AU - Canetta, Alessandro

AU - Fracasso, Claudia

AU - Caccia, Silvio

AU - Cervo, Luigi

AU - Invernizzi, Roberto W.

PY - 2009/7

Y1 - 2009/7

N2 - We recently found that the response of DBA/2 mice to SSRIs in the forced swim test (FST) was impaired and they also had a smaller basal and citalopram-stimulated increase in brain extracellular serotonin (5-HT) than responder strains. We employed intracerebral microdialysis, FST and selective antagonists of 5-HT1A and 5-HT2C receptors to investigate whether enhancing the increase in extracellular 5-HT reinstated the anti-immobility effect of citalopram in the FST. WAY 100635 (0.3 mg/kg s.c.) or SB 242084 (1 mg/kg s.c.), respectively a selective 5-HT1A and 5-HT2C receptor antagonist, raised the effect of citalopram (5 mg/kg) on extracellular 5-HT in the medial prefrontal cortex of DBA/2N mice (citalopram alone 5.20.3 fmol/20 l, WAY 100635+citalopram 9.92.1 fmol/20 l, SB 242084+ citalopram 7.61.0 fmol/20 l) to the level reached in responder mice given citalopram alone. The 5-HT receptor antagonists had no effect on the citalopram-induced increase in extracellular 5-HT in the dorsal hippocampus. The combination of citalopram with WAY 100635 or SB 242084 significantly reduced immobility time in DBA/2N mice that otherwise did not respond to either drug singly. Brain levels of citalopram in mice given citalopram alone or with 5-HT antagonists did not significantly differ. The results confirm that impaired 5-HT transmission accounts for the lack of effect of citalopram in the FST and suggest that enhancing the effect of SSRIs on extracellular 5-HT, through selective blockade of 5-HT1A and 5-HT2C receptors, could be a useful strategy to restore the response in treatment-resistant depression.

AB - We recently found that the response of DBA/2 mice to SSRIs in the forced swim test (FST) was impaired and they also had a smaller basal and citalopram-stimulated increase in brain extracellular serotonin (5-HT) than responder strains. We employed intracerebral microdialysis, FST and selective antagonists of 5-HT1A and 5-HT2C receptors to investigate whether enhancing the increase in extracellular 5-HT reinstated the anti-immobility effect of citalopram in the FST. WAY 100635 (0.3 mg/kg s.c.) or SB 242084 (1 mg/kg s.c.), respectively a selective 5-HT1A and 5-HT2C receptor antagonist, raised the effect of citalopram (5 mg/kg) on extracellular 5-HT in the medial prefrontal cortex of DBA/2N mice (citalopram alone 5.20.3 fmol/20 l, WAY 100635+citalopram 9.92.1 fmol/20 l, SB 242084+ citalopram 7.61.0 fmol/20 l) to the level reached in responder mice given citalopram alone. The 5-HT receptor antagonists had no effect on the citalopram-induced increase in extracellular 5-HT in the dorsal hippocampus. The combination of citalopram with WAY 100635 or SB 242084 significantly reduced immobility time in DBA/2N mice that otherwise did not respond to either drug singly. Brain levels of citalopram in mice given citalopram alone or with 5-HT antagonists did not significantly differ. The results confirm that impaired 5-HT transmission accounts for the lack of effect of citalopram in the FST and suggest that enhancing the effect of SSRIs on extracellular 5-HT, through selective blockade of 5-HT1A and 5-HT2C receptors, could be a useful strategy to restore the response in treatment-resistant depression.

KW - 5-HT1A receptors

KW - 5-HT2C receptors

KW - FST

KW - Intracerebral microdialysis

KW - SSRIs

KW - TPH-2

UR - http://www.scopus.com/inward/record.url?scp=68849105373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849105373&partnerID=8YFLogxK

U2 - 10.1017/S1461145708009760

DO - 10.1017/S1461145708009760

M3 - Article

VL - 12

SP - 793

EP - 803

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 6

ER -